Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 20726 - 20750 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cyclophosphamide	Approved Investigational	HLA-F	3134	upregulated	Cyclophosphamide results in increased expression of HLA-F mRNA	6p22.1	A20660
Cyclophosphamide	Approved Investigational	HMGCS1	3157	upregulated	Cyclophosphamide metabolite results in increased expression of HMGCS1 mRNA	5p12	A20727
Cyclophosphamide	Approved Investigational	HSPA1A	3303	upregulated	Cyclophosphamide results in increased expression of HSPA1A mRNA	6p21.33	A21867
Cyclophosphamide	Approved Investigational	HSPA1B	3304	upregulated	Cyclophosphamide metabolite results in increased expression of HSPA1B mRNA	6p21.33	A20727
Cyclophosphamide	Approved Investigational	HSPA5	3309	upregulated	Cyclophosphamide metabolite results in increased expression of HSPA5 mRNA	9q33.3	A20727
Cyclophosphamide	Approved Investigational	HSPH1	10808	upregulated	Cyclophosphamide metabolite results in increased expression of HSPH1 mRNA	13q12.3	A20727
Cyclophosphamide	Approved Investigational	HYLS1	219844	downregulated	Cyclophosphamide metabolite results in decreased expression of HYLS1 mRNA	11q24.2	A20727
Cyclophosphamide	Approved Investigational	ICAM3	3385	downregulated	Cyclophosphamide results in decreased expression of ICAM3 mRNA	19p13.2	A21865
Cyclophosphamide	Approved Investigational	ID2	3398	downregulated	Cyclophosphamide metabolite results in decreased expression of ID2 mRNA	2p25.1	A20727
Cyclophosphamide	Approved Investigational	IDI1	3422	upregulated	Cyclophosphamide metabolite results in increased expression of IDI1 mRNA	10p15.3	A20727
Cyclophosphamide	Approved Investigational	IER3	8870	downregulated	Cyclophosphamide metabolite results in decreased expression of IER3 mRNA	6p21.33	A20727
Cyclophosphamide	Approved Investigational	IER5	51278	upregulated	Cyclophosphamide results in increased expression of IER5 mRNA	1q25.3	A21863
Cyclophosphamide	Approved Investigational	IFRD1	3475	downregulated	Cyclophosphamide metabolite results in decreased expression of IFRD1 mRNA	7q31.1	A20727
Cyclophosphamide	Approved Investigational	IGFBP5	3488	downregulated	Cyclophosphamide results in decreased expression of IGFBP5 mRNA	2q35	A20660
Cyclophosphamide	Approved Investigational	ISG15	9636	upregulated	Cyclophosphamide results in increased expression of ISG15 mRNA	1p36.33	A21863
Cyclophosphamide	Approved Investigational	ISL2	64843	downregulated	Cyclophosphamide metabolite results in decreased expression of ISL2 mRNA	15q24.3	A20727
Cyclophosphamide	Approved Investigational	KBTBD11	9920	downregulated	Cyclophosphamide results in decreased expression of KBTBD11 mRNA	8p23.3	A21865
Cyclophosphamide	Approved Investigational	KCNQ4	9132	downregulated	Cyclophosphamide results in decreased expression of KCNQ4 mRNA	1p34.2	A20660
Cyclophosphamide	Approved Investigational	KIF21B	23046	downregulated	Cyclophosphamide metabolite results in decreased expression of KIF21B mRNA	1q32.1	A20727
Cyclophosphamide	Approved Investigational	KRCC1	51315	downregulated	Cyclophosphamide metabolite results in decreased expression of KRCC1 mRNA	2p11.2	A20727
Cyclophosphamide	Approved Investigational	KRT80	144501	upregulated	Cyclophosphamide results in increased expression of KRT80 mRNA	12q13.13	A21863
Cyclophosphamide	Approved Investigational	LAMC2	3918	upregulated	Cyclophosphamide results in increased expression of LAMC2 mRNA	1q25.3	A21863
Cyclophosphamide	Approved Investigational	LGALS1	3956	upregulated	Cyclophosphamide results in increased expression of LGALS1 mRNA	22q13.1	A21865
Cyclophosphamide	Approved Investigational	LGALS7	3963	upregulated	Cyclophosphamide results in increased expression of LGALS7 mRNA	19q13.13	A21863
Cyclophosphamide	Approved Investigational	LSG1	55341	downregulated	Cyclophosphamide results in decreased expression of LSG1 mRNA	3q29	A20660

Displaying entries 20726 - 20750 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability